ubamatamab
regeneron
['ubamata', 'regn4018', 'solid tumor', 'regeneron']
pnbn news: novel regeneron bispecific antibodies show encouraging anti-tumor activity in two advanced solid tumors: first-in-class phase 1 data presented at esmo for ubamatamab (regn4018; muc16xcd3) in ... #biotech #news 
Life science news and jobs from Pennsylvania, New York and New Jersey, including Philadelphia & NYC. Part of @BiotechNetworks, connecting #biotech since 2008.